Clinical trial
Post-market Study for At-home Evaluation of Near Visual Acuity With OdySight, a Smartphone Based Medical Application in Comparison to a Standardized Method (TIL002)
NCT05510479 is registered in ClinicalTrials.gov with Tilak Healthcare as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-market Study for At-home Evaluation of Near Visual Acuity With OdySight, a Smartphone Based Medical Application in Comparison to a Standardized Method (TIL002)
- Lead sponsor
- Tilak Healthcare
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 5, 2021
- Completion date
- May 11, 2022
- Enrollment
- 58 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
visual impairment